News
Vir Biotechnology has a strong cash position and is poised to generate definitive data in antivirals and oncology, making ...
A three-antigen hepatitis B vaccine (3A-HBV) induced higher hepatitis B surface antibody (anti-HB) concentrations and seroprotection versus the single-antigen vaccine (1A-HBV) in a phase III trial.
As mentioned, the hepatitis D virus encodes two different proteins from the same open reading frame (ORF): the small hepatitis D antigen (S-HDAg), 195 amino acids, and the large hepatitis D ...
Hepatitis B core antigen expression was observed in 12 patients (36%). The HBcAg staining was restricted to the nucleus in most cases (10 of 12 patients).
At present, all hepatitis B vaccines contain hepatitis B antigens to help the immune system generate an immune response. In addition, some vaccines may also contain other ingredients, such as ...
Screening for hepatitis B requires a blood test that looks for antigens and antibodies for hepatitis B virus (HBV). Read on to find out about screening and interpreting results.
Metabolic dysfunction-associated steatotic liver disease is prevalent among patients with chronic hepatitis B in Europe and ...
At a time hepatitis B programs seem to be dropping like flies, Vir Biotechnology has some good news. Its gene-silencing drug cut levels of the hepatitis B surface antigen in a small phase 2 study ...
HHS Secretary Robert F. Kennedy Jr. and the CDC vaccine panel have been casting doubt on the hepatitis B shot and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results